The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells

The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells

Li Wang,1 Qian Yang,2 Shaoyong Peng,3 Xiaoxia Liu1,31Department of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, People’s Republic of China; 2Department of Orthopedics, Luoyang No.1 Hospital of TCM, Luoyang 471000, People’s Republic of China; 3The Si...

Full description

Bibliographic Details
Main Authors: Wang L, Yang Q, Peng S, Liu X
Format: Article
Language:English
Published: Dove Medical Press 2019-07-01
Series:OncoTargets and Therapy
Subjects:
Persister cells
drug-resistance
sorafenib
glycolysis inhibitor
antitumor
Online Access:https://www.dovepress.com/the-combination-of-the-glycolysis-inhibitor-2-dg-and-sorafenib-can-be--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/the-combination-of-the-glycolysis-inhibitor-2-dg-and-sorafenib-can-be--peer-reviewed-article-OTT

Similar Items